Global Prescription Digital Therapeutics (PDTx) Market is Expected to Grow at 21.6% in the Forecast Period of 2020 to 2027

The Prescription Digital Therapeutics (PDTx) Industry will relinquish an approximated estimate at a frequency of 21.6% for the projection space of 2020 to 2027 with factor such as increasingly dominant role of mobile technology and artificial intelligence (AI) in our everyday lives.

Rising prevalence of chronic diseases and increasing technological advancement in the pharmaceutical and healthcare field acts as a major factor for the growth of the prescription digital therapeutics (PDTx) market.  However, privacy issues in prescription digital healthcare may obstruct the growth of the prescription digital therapeutics (PDTx) market in the given forecast period.  

Global Prescription Digital Therapeutics (PDTx) Market Scenario   

According to Data Bridge Market Research, the market for prescription digital therapeutics (PDTx) in North America has the highest market share followed by Europe and Asia-Pacific. Market leader is Omada Health, Inc. which accounts an estimated market share of approximately 15.84% in the global market. The company has gained outstanding sale by providing advanced therapies for metabolic disease treatment.

  • In May 2020, Omada Health, Inc., a company which provides digital health tools for the patients suffering from chronic conditions, raised USD 57.00 million from the perceptive advisors and spent USD 30.00 million of it acquiring physera. Physera specializes in virtual physical therapy.

Prescription Digital Therapeutics (PDTx) MarketTrends Impacting the Prescription Digital Therapeutics (PDTx) Market

Now the question is which other regions Omada Health, Inc., ResMed and SAMSUNG are targeting? Data Bridge Market Research has estimated a large growth in North America prescription digital therapeutics (PDTx) market and the market leaders targeting the U.S., Canada and Mexico to be their next revenue pockets for 2020.

The prescription digital therapeutics (PDTx) market is becoming more competitive every year with companies such as Omada Health, Inc., ResMed and SAMSUNG as they are the top dominating companies in prescription digital therapeutics (PDTx) having advanced products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global prescription digital therapeutics (PDTx) market.      

For more analysis on the global prescription digital therapeutics (PDTx) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prescription-digital-therapeutics-dtx-market

Global Prescription Digital Therapeutics (PDTx) Market Development

  • In September 2020, Pear Therapeutics, Inc. announces availability of RESET and RESET-O to Wellpath Community Care Center Patients for the treatment of addiction including substance used disorders and opioid used disorders.

Scope of the Global Prescription Digital Therapeutics (PDTx) Market

Global prescription digital therapeutics (PDTx) market is segmented on the basis of countries into the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

  • All country-based analysis of global prescription digital therapeutics (PDTx) market is further analyzed based on further segmentation. On the basis of mechanism, the prescription digital therapeutics (PDTx) market is segmented into input mechanisms and output mechanisms. On the basis of category, the prescription digital therapeutics (PDTx) market is segmented into medication augmentation and medication replacement. On the basis of treatment, the prescription digital therapeutics (PDTx) market is segmented into outpatient treatment and monotherapy. On the basis of software, the prescription digital therapeutics (PDTx) market is segmented into software for respiratory conditions, software for mental health, software for opioid use disorder, software for diabetes and others. On the basis of services, the prescription digital therapeutics (PDTx) market is segmented into behavioral microservices and medical microservices. On the basis of app accessibility, the prescription digital therapeutics (PDTx) market is segmented into android, iOS and windows. On the basis of app type, the prescription digital therapeutics (PDTx) market is segmented into native app and web app. On the basis of application, the prescription digital therapeutics (PDTx) market is segmented into substance use disorder (SUD), opioid use disorder (OUD), attention deficit/hyperactivity disorder (ADHD), alzheimer’s disease, major depressive disorder (MDD), insomnia, epilepsy, movement disorder, multiple sclerosis, migraine, autism spectrum disorder, oncology, inflammation, respiratory, cardiovascular, pain management, metabolic conditions and others. On the basis of patients, the prescription digital therapeutics (PDTx) market is segmented into children and adults.

To know more about the study https://www.databridgemarketresearch.com/reports/global-prescription-digital-therapeutics-dtx-market

Key Pointers Covered in Global Prescription Digital Therapeutics (PDTx) Market Industry Trends and Forecast to 2027

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Omada Health, Inc.
  • ResMed
  • SAMSUNG
  • GAIA AG
  • Pear Therapeutics, Inc.
  • Welldoc’s Bluestar
  • Solera Network
  • Akili Interactive Labs, Inc.
  • Better Therapeutics, LLC
  • BigHealth
  • Biofourmis
  • Click Therapeutics, Inc.
  • Happify, Inc.
  • Limbix Health, Inc.
  • Naturalcycles Nordic AB
  • NuvoAir AB
  • Sensyne Health plc
  • Voluntis
  • Xealth

Above are the key players covered in the report, to know about more and exhaustive list of prescription digital therapeutics (PDTx) companies’, contact us  https://www.databridgemarketresearch.com/toc/?dbmr=global-prescription-digital-therapeutics-dtx-market

Research Methodology: Global Prescription Digital Therapeutics (PDTx) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Pharmacists, Hospitals, Clinicians and Technicians, Academic Professionals and Researchers
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/